Acyclovir suppression dose

Geriatrics: The pharmacokinetics of acyclovir following single- and multiple-dose oral For the suppression of genital herpes, the usual dose

by L Szenborn 2024 Cited by 20After oral acyclovir administration at a dose of 200 mg 5 times chronic suppression with acyclovir. Acyclovir Study Group. J Infect

acyclovir-suppressive therapy. Thus, the low dose of acyclovir suppressive therapy did not affect the susceptibility to acyclovir or increase the fre-quency of acyclovir-resistant viruses in the geni-tal lesions. Keywords: genital herpes, herpes simplex virus, acyclovir, susceptibility Introduction 2024 International Medical Press

smear samples was determined in patients on suppressive therapy and in those naive to acyclovir therapy.We could not find any affect of long-term, low-dose acyclovir suppressive therapy on the susceptibility to acyclovir and on the frequen-cy of acyclovir-resistance of the virus population isolated directly from lesions of genital herpes.

Suppressive therapy with acyclovir, famciclovir, or valacyclovir to a high-dose suppressive valacyclovir group (1,000 mg bid) in. ART

cy of acyclovir-resistance of the virus population isolated directly from lesions of genital herpes. This finding suggests that long-term, low-dose acyclovir suppressive therapy for Antiviral Chemistry Chemotherapy 3 239 Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of

This study used a rather high dose of acyclovir or valacyclovir for VZV prophylaxis. Long-Term Suppressive Acyclovir Use after Hematopoietic Stem Cell

We use 200 mg oral acyclovir once a day for daily low-dose acyclovir suppressive therapy in our patients with genital herpes caused by HSV-2 who have six or more recur-rences per year. Thus, this study is designed to characterize the affect of long-term, low-dose acyclovir suppressive ther-apy on susceptibility to acyclovir and frequency of

We use acyclovir 400 mg three times daily as suppressive therapy. Doses for suppressive therapy are higher in pregnant compared with nonpregnant women because